Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade

被引:97
作者
Harir, Noria [2 ]
Boudot, Cedric [2 ]
Friedbichler, Katrin [1 ]
Sonneck, Karoline [3 ]
Kondo, Rudin [3 ]
Martin-Lanneree, Severine [4 ,5 ]
Kenner, Lukas [1 ,6 ]
Kerenyi, Marc [7 ]
Yahiaoui, Saliha [2 ]
Gouilleux-Gruart, Valerie [2 ]
Gondry, Jean [8 ]
Benit, Laurence [4 ,5 ]
Dusanter-Fourt, Isabelle [4 ,5 ]
Lassoued, Kaiss [2 ]
Valent, Peter [3 ]
Moriggl, Richard [1 ]
Gouilleux, Fabrice [2 ]
机构
[1] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria
[2] Univ Picardie J Verne, Fac Med, INSERM, EMI 351, Amiens, France
[3] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[4] Univ Paris 05, Inst Cochin Genet Mol, CNRS, UMR 8104, Paris, France
[5] INSERM, U567, Paris, France
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
[7] Med Univ Vienna, Div Mol Biol, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria
[8] Ctr Hosp Univ, Ctr Gynecol Obstet, Amiens, France
基金
奥地利科学基金会;
关键词
D O I
10.1182/blood-2007-09-115477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The D816V-mutated variant of Kit triggers multiple signaling pathways and is considered essential for malignant transformation in mast cell (MC) neoplasms. We here describe that constitutive activation of the Stat5-PI3K-Akt-cascade controls neoplastic MC development. Retrovirally transduced active Stat5 (cS5F) was found to trigger PI3K and Akt activation, and to transform murine bone marrow progenitors into tissue-infiltrating MCs. Primary neoplastic Kit D816V(+) MCs in patients with mastocytosis also displayed activated Stat5, which was found to localize to the cytoplasm and to form a signaling complex with PI3K, with consecutive Akt activation. Finally, the knock-down of either Stat5 or Akt activity resulted in growth inhibition of neoplastic Kit D816V(+) MCs. These data suggest that a downstream Stat5-PI3K-Akt signaling cascade is essential for Kit D816V-mediated growth and survival of neoplastic MCs.
引用
收藏
页码:2463 / 2473
页数:11
相关论文
共 50 条
[21]   Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3-and KIT-Driven Leukemogenesis [J].
Chatterjee, Anindya ;
Ghosh, Joydeep ;
Ramdas, Baskar ;
Mali, Raghuveer Singh ;
Martin, Holly ;
Kobayashi, Michihiro ;
Vemula, Sasidhar ;
Canela, Victor H. ;
Waskow, Emily R. ;
Visconte, Valeria ;
Tiu, Ramon V. ;
Smith, Catherine C. ;
Shah, Neil ;
Bunting, Kevin D. ;
Boswell, H. Scott ;
Liu, Yan ;
Chan, Rebecca J. ;
Kapur, Reuben .
CELL REPORTS, 2014, 9 (04) :1333-1348
[22]   Detection of activated STAT5 in neoplastic mast cells in patients with systemic mastocytosis: Role of c-kit D816V [J].
Sonneck, K ;
Mayerhofer, M ;
Gleixner, KV ;
Kerenyi, M ;
Krauth, MT ;
Fritz, R ;
Sillaber, C ;
Moriggl, R ;
Valent, P .
BLOOD, 2005, 106 (11) :981A-981A
[23]   STAT3/STAT5 BALANCE AS A BIOMARKER IN RA: CTLA4-IG AND T CELL DIFFERENTIATION THROUGH STAT SIGNALING [J].
Alivernini, Stefano ;
Tolusso, Barbara ;
Fedele, Anna Laura ;
Di Mario, Clara ;
Petricca, Luca ;
Gigante, Maria Rita ;
Ferraccioli, Gianfranco ;
Gremese, Elisa .
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 :1100-1100
[24]   Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling [J].
Hayashi, Hideko ;
Tsuchiya, Yoshiki ;
Nakayama, Kei ;
Satoh, Takayuki ;
Nishida, Eisuke .
GENES TO CELLS, 2008, 13 (09) :941-947
[25]   PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma [J].
I. Garces de los Fayos Alonso ;
L. Zujo ;
I. Wiest ;
P. Kodajova ;
G. Timelthaler ;
S. Edtmayer ;
M. Zrimšek ;
S. Kollmann ;
C. Giordano ;
M. Kothmayer ;
H. A. Neubauer ;
S. Dey ;
M. Schlederer ;
B. S. Schmalzbauer ;
T. Limberger ;
C. Probst ;
O. Pusch ;
S. Högler ;
S. Tangermann ;
O. Merkel ;
A. I. Schiefer ;
C. Kornauth ;
N. Prutsch ;
M. Zimmerman ;
B. Abraham ;
J. Anagnostopoulos ;
L. Quintanilla-Martinez ;
S. Mathas ;
P. Wolf ;
D. Stoiber ;
P. B. Staber ;
G. Egger ;
W. Klapper ;
W. Woessmann ;
T. A. Look ;
P. Gunning ;
S. D. Turner ;
R. Moriggl ;
S. Lagger ;
L. Kenner .
Molecular Cancer, 21
[26]   PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma [J].
Alonso, I. Garces de los Fayos ;
Zujo, L. ;
Wiest, I ;
Kodajova, P. ;
Timelthaler, G. ;
Edtmayer, S. ;
Zrimsek, M. ;
Kollmann, S. ;
Giordano, C. ;
Kothmayer, M. ;
Neubauer, H. A. ;
Dey, S. ;
Schlederer, M. ;
Schmalzbauer, B. S. ;
Limberger, T. ;
Probst, C. ;
Pusch, O. ;
Hogler, S. ;
Tangermann, S. ;
Merkel, O. ;
Schiefer, A., I ;
Kornauth, C. ;
Prutsch, N. ;
Zimmerman, M. ;
Abraham, B. ;
Anagnostopoulos, J. ;
Quintanilla-Martinez, L. ;
Mathas, S. ;
Wolf, P. ;
Stoiber, D. ;
Staber, P. B. ;
Egger, G. ;
Klapper, W. ;
Woessmann, W. ;
Look, T. A. ;
Gunning, P. ;
Turner, S. D. ;
Moriggl, R. ;
Lagger, S. ;
Kenner, L. .
MOLECULAR CANCER, 2022, 21 (01)
[27]   The receptor tyrosine kinase Kit signaling through phosphatidylinositol (PI) 3-kinase stimulates mouse Leydig cell steroidogenesis. [J].
Rothschild, G ;
Sottas, CM ;
Kissel, H ;
Hardy, MP ;
Besmer, P .
BIOLOGY OF REPRODUCTION, 2001, 64 :210-210
[28]   Interleukin-5 suppresses Vascular Endothelial Growth Factor -induced angiogenesis through STAT5 signaling [J].
Bucher, Felicitas ;
Lee, Jungho ;
Shin, Sanghee ;
Kim, Minseok S. ;
Oh, Yong-Seok ;
Ha, Sanghoon ;
Zhang, Hongkai ;
Yea, Kyungmoo .
CYTOKINE, 2018, 110 :397-403
[29]   Endomembrane HRas controls the PI3 kinase/Akt/eNOS signaling cascade in VEGF induced endothelial cell migration [J].
Haeussler, Dagmar ;
Burgoyne, Joseph R. ;
Hou, Xiuyun ;
Pimental, David R. ;
Cohen, Richard A. ;
Bachschmid, Markus M. .
FASEB JOURNAL, 2013, 27
[30]   PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway [J].
Ren, Yu ;
Zhou, Xuan ;
Qi, Yanbin ;
Li, Guolan ;
Mei, Mei ;
Yao, Zhi .
ONCOLOGY REPORTS, 2012, 28 (03) :943-948